Pfizer to in-license Absorption Systems' BCRP-MDCK cells

[News]

Absorption Systems, a leader in novel test systems for drug transporters, announces a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein).

More... (http://www.news-medical.net/news/20140715/Pfizer-to-in-license-Absorption-Systems-BCRP-MDCK-cells.aspx)